According to article published in the archives of Neurology research magazine (Arch Neurol. 2010 Feb; 67 (2): 154-60) clinical trial to evaluate the safety and tolerability of Dimebon (latrepirdine) in Huntington’s disease and explore their effects on cognitive function, behavior, and motor symptoms showed positive preliminary results. The clinical trial was a double-blind, multicenter, which […]